Trazodone

Trazodone works differently from most antidepressants, affecting the serotonin system through multiple complementary mechanisms ^{[1, 2]}. It is classified as a serotonin antagonist and reuptake inhibitor (SARI), which describes its dual action on the serotonin system.

Serotonin receptor antagonism: Trazodone potently blocks certain serotonin receptors — specifically the 5-HT2A and 5-HT2C receptors ^{[1, 3]}. Blocking 5-HT2A receptors is thought to promote sleep, reduce anxiety, and may contribute to its antidepressant effect. This receptor blockade is also why trazodone causes significantly less sexual dysfunction than SSRIs (which stimulate 5-HT2A receptors as an unwanted consequence of increased serotonin) ^{[3, 4]}.

Serotonin reuptake inhibition: Like SSRIs, trazodone also blocks the serotonin transporter (SERT), increasing serotonin availability in the brain ^{[1, 3]}. However, this effect is weaker than that of dedicated SSRIs like sertraline or fluoxetine, which is why higher doses are needed for antidepressant efficacy.

Sedation through histamine and alpha blockade: Trazodone blocks histamine H1 receptors and alpha-1 adrenergic receptors, both of which contribute to its prominent sedating and sleep-promoting effects ^{[1, 3]}. These sedative mechanisms dominate at low doses (25-100 mg), which is why trazodone is one of the most widely prescribed medications for insomnia in the United States — despite this use being officially off-label ^{[4, 5]}.

Dose-dependent effects: At low doses (25-100 mg), the sedating 5-HT2A antagonism and histamine/alpha blockade dominate, producing sleep-promoting effects. At higher doses (150-400 mg), the serotonin reuptake inhibition becomes more pharmacologically significant, contributing to antidepressant effects in addition to the receptor antagonism ^{[1, 3]}.

For insomnia (low-dose use, 25-100 mg) [1, 4, 5]:

Take trazodone approximately 30 minutes before bedtime. Drowsiness onset typically occurs within 30-60 minutes ^[1]. Most patients experience improved ability to fall asleep from the first night of use. Sleep quality improvements (fewer nighttime awakenings, more restorative sleep) develop over the first week ^[5].

Morning grogginess (a "hangover" effect) may occur initially, particularly at doses above 50 mg ^{[1, 4]}. This usually improves within several days as your body adjusts. If morning grogginess persists, taking a lower dose or taking it slightly earlier in the evening may help. Unlike benzodiazepines and Z-drugs, trazodone does not produce tolerance, physical dependence, or rebound insomnia upon discontinuation when used for insomnia ^{[4, 5]}.

For depression (150-400 mg/day) [1, 3]:

Sedation is prominent during the first 1-2 weeks and is the primary reason for dose-related discontinuation ^[1]. Antidepressant effects typically take 2-4 weeks to become apparent, consistent with other serotonergic antidepressants. Your doctor will start at a lower dose (typically 150 mg/day in divided doses) and gradually increase by 50 mg/day every 3-4 days to minimize side effects ^[1]. The dose is usually divided (twice or three times daily) to reduce peak sedation.

Side effects [1, 2]: The most common side effects include drowsiness/sedation (affecting up to 40% of patients at antidepressant doses), dizziness, dry mouth, nausea, and headache. Orthostatic hypotension (dizziness when standing up) is related to alpha-1 blockade and is more common in elderly patients ^{[1, 6]}. Priapism (prolonged, painful erection) is a rare but serious complication requiring immediate medical attention — occurring in approximately 1 in 6,000-8,000 male patients ^{[1, 7]}.

Important: Take trazodone with food or a snack to improve absorption and reduce dizziness ^{[1, 2]}.

Food — take with food: Trazodone should be taken with food or a snack ^{[1, 2]}. Food increases absorption by approximately 20% and, more importantly, significantly reduces the risk of dizziness and lightheadedness caused by orthostatic hypotension ^[1]. Taking trazodone on an empty stomach can lead to more pronounced drops in blood pressure upon standing.

Alcohol — avoid completely: Alcohol must be avoided while taking trazodone ^[1]. Both substances are CNS depressants, and combining them produces additive sedation that can cause excessive drowsiness, dangerously low blood pressure, impaired breathing, and poor coordination ^{[1, 6]}. This combination significantly increases fall risk, particularly in elderly patients. Even one alcoholic drink can meaningfully amplify trazodone's sedative effects.

CNS depressant interactions: Trazodone's sedative effects are amplified by other CNS depressants including benzodiazepines, opioids, antihistamines, and other sleep medications ^{[1, 6]}. If trazodone is being used as a sleep aid, other sedating medications taken at bedtime should be reviewed with your healthcare provider to avoid excessive sedation.

Drug interactions of clinical significance [1, 2]: - CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) can increase trazodone levels — a lower trazodone dose may be needed - CYP3A4 inducers (carbamazepine, phenytoin) can decrease trazodone levels — a higher dose may be required - Serotonergic medications (SSRIs, SNRIs, MAOIs, tramadol, triptans) — risk of serotonin syndrome when combined with trazodone - MAOIs — contraindicated; do not use within 14 days of each other due to risk of serotonin syndrome ^[1]

For insomnia (off-label but widely used) [1, 4, 5]: - Starting dose: 25-50 mg at bedtime - Usual effective range: 50-100 mg at bedtime - Maximum for insomnia: 200 mg (rarely needed) - Take 30 minutes before desired sleep time, with a light snack

For major depressive disorder [1, 3]: - Starting dose: 150 mg/day in divided doses (e.g., 50 mg three times daily) - Titration: Increase by 50 mg/day every 3-4 days as tolerated - Usual therapeutic range: 150-400 mg/day - Maximum: 400 mg/day (outpatient), 600 mg/day (inpatient) - Divide doses to minimize peak sedation

Extended-release (Oleptro) [1]: - Starting dose: 150 mg once daily at bedtime - Titration: Increase by 75 mg/day every 3 days - Maximum: 375 mg/day - Swallow whole or break in half along the score line; do not crush or chew

Available formulations [1, 2]: Immediate-release tablets (50, 100, 150, 300 mg), extended-release tablets (150, 300 mg). The 150 mg and 300 mg IR tablets are scored and can be split.

Elderly patients: Start at the lower end of the dosing range (25 mg for insomnia, 75-100 mg/day for depression) due to increased sensitivity to orthostatic hypotension and sedation ^{[1, 6]}.

Discontinuation: When stopping trazodone after prolonged use, taper gradually over 1-2 weeks to minimize discontinuation symptoms (though these are generally milder than with SSRIs/SNRIs) ^[1].

Generic trazodone is one of the least expensive prescription medications available, making it remarkably accessible for both insomnia and depression ^{[8, 9]}.

Pricing [8, 9]: - Generic trazodone immediate-release: $4-10/month for a 30-day supply - Available on virtually all $4 generic programs (Walmart, Kroger, Costco, CVS, Walgreens) - Even the 100 mg tablets (commonly used for insomnia) cost well under $15/month - GoodRx coupons can reduce cash prices to $3-8/month without insurance

Brand status: Brand-name Desyrel has been discontinued — only generic trazodone immediate-release is available ^{[1, 8]}. The extended-release formulation (Oleptro) is the only branded product still available and costs significantly more ($200-400/month), but it is rarely necessary — most patients do well with the generic immediate-release tablets ^[8].

Cost comparison with other sleep aids: Trazodone is dramatically cheaper than most prescription sleep medications ^{[4, 5]}: - Generic zolpidem (Ambien): $10-25/month - Generic eszopiclone (Lunesta): $15-50/month - Suvorexant (Belsomra): $300+/month - Lemborexant (Dayvigo): $350+/month

As a non-controlled substance with no abuse potential, trazodone also avoids the prescribing restrictions and monitoring requirements associated with Schedule IV sleep medications ^{[4, 5]}.

Value perspective: At approximately $4-10/month, trazodone provides effective sleep improvement for a fraction of the cost of newer branded sleep medications, with a well-understood safety profile spanning decades of clinical use.

Pregnancy: Trazodone should be used during pregnancy only if the potential benefit justifies the potential risk ^{[1, 2]}. There are limited well-controlled studies in pregnant women.

Animal studies at high doses have shown adverse effects including increased fetal resorptions and congenital abnormalities ^[1]. Human data are limited but have not established a clear pattern of increased birth defects ^[7]. However, use of serotonergic medications during the third trimester may cause neonatal adaptation syndrome (neonatal withdrawal), with symptoms including respiratory distress, feeding difficulties, jitteriness, irritability, temperature instability, and seizures in the newborn ^{[1, 7]}.

The decision to use trazodone during pregnancy should weigh the risks of medication exposure against the risks of untreated maternal depression or insomnia, which can themselves adversely affect pregnancy outcomes (preterm birth, low birth weight, postpartum depression) ^[7]. Discuss with a healthcare provider experienced in perinatal mental health.

Breastfeeding: Trazodone and its metabolites are excreted in breast milk ^{[1, 2]}. The relative infant dose is estimated to be low (less than 1% of the weight-adjusted maternal dose) ^[7]. Short-term use at low doses for insomnia is generally considered low risk during breastfeeding, based on limited available data. Monitor the infant for excessive sedation, poor feeding, and irritability. If using trazodone for depression at higher doses, the infant exposure increases proportionally, and closer monitoring is warranted.

Alternative considerations: For insomnia during pregnancy, non-pharmacologic approaches (sleep hygiene, cognitive behavioral therapy for insomnia) should be tried first ^[7]. If medication is necessary, discuss the relative safety profiles of available options with your healthcare provider.

Generic trazodone immediate-release is the standard form available in the United States — the former brand-name Desyrel has been discontinued ^{[1, 8]}. There is no clinical reason to seek a brand-name version, and all generic trazodone products are rated as therapeutically equivalent by the FDA.

Available generic strengths: 50 mg, 100 mg, 150 mg, and 300 mg tablets ^{[1, 2, 8]}. The 150 mg and 300 mg tablets are scored, allowing them to be split for intermediate dosing.

Extended-release formulation: The only currently branded trazodone product is Oleptro (trazodone extended-release), which provides once-daily dosing for depression ^[1]. Oleptro costs significantly more ($200-400/month) than generic immediate-release trazodone ($4-10/month) and is rarely necessary ^{[8, 9]}. For insomnia use, the immediate-release tablet taken at bedtime is the standard approach. For depression, dividing the immediate-release tablets into multiple daily doses achieves similar therapeutic coverage at a fraction of the cost.

Switching note: Patients should not switch between immediate-release and extended-release formulations without medical guidance, as the dosing schedule and pharmacokinetic profile differ ^[1]. The extended-release formulation is designed for once-daily bedtime dosing, while immediate-release tablets are typically divided throughout the day for depression.